Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fludrocortisone acetate tablets for salt-wasting primary chronic adrenal insufficiency
CTR20244655Phase 4Active
- Sponsor
- Hefei Future Drug Development
- Start
- Jun 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of fludrocortisone in Addison's disease, sponsored by Hefei Future Drug Development. Started Jun 2025; status: active.
02
Drugs
fludrocortisone
03
Conditions
Addison's disease
Beyond the preview
Go deeper on CTR20244655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20244655.